In this review, we will discuss the management of ALL in the adult population, in the context of the recently published guidelines from the NCCN. We will focus in particular on the strides being made in salvage and targeted approaches.
Michael S. Mathisen, PharmD
Advertisement
Articles by Michael S. Mathisen, PharmD
Advertisement
Latest Updated Articles
- Treatment of Adult Acute Lymphoblastic Leukemia (ALL) With a Focus on Emerging Investigational and Targeted Therapies
Published: September 12th 2012 | Updated:
Advertisement
Advertisement
